NCT03430427

Brief Summary

Rapidly accumulating evidence indicates that the central nervous system (CNS) plays a pivotal role in mobility function with age-associated CNS changes strongly contributing to declining mobility. Studies linking the brain to mobility have used anatomical measures like brain volume and white matter integrity, and suggest that damage to the connecting fibers of the brain (white matter) is related to mobility impairment. Unfortunately, age-related structural white matter damage appears irreversible and only indirectly indicates the functional connectivity between brain regions. It is believed that functional brain network analyses have the potential to identify individuals that may benefit from interventions prior to the development of irreversible white matter lesions. The current project will assess both physical and cognitive function and integrate these variables with measures of brain network connectivity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
192

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 26, 2018

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 12, 2018

Completed
5 months until next milestone

Study Start

First participant enrolled

July 20, 2018

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 12, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 12, 2023

Completed
Last Updated

August 18, 2023

Status Verified

August 1, 2023

Enrollment Period

5 years

First QC Date

January 26, 2018

Last Update Submit

August 14, 2023

Conditions

Keywords

BNETBrain NetworksMobility FunctionSMCCS

Outcome Measures

Primary Outcomes (1)

  • Change in Extended Short Physical Performance Battery (eSPPB)

    The expanded Short Physical Performance Battery (eSPPB) is a modified version of a widely used assessment of lower extremity physical function that consists of 3 standing balance tasks held for 10 seconds each (side-by-side, tandem and semi-tandem), two 4-m walk tests to assess usual gait speed, and 5 repeated chair stands. To minimize ceiling effects and maximize overall dispersion of test scores, the eSPPB increases the holding time of the semi- and full-tandem stands to 30 seconds and adds a single leg stand and a narrow walk test of balance (walking at usual pace within lines of tape spaced 20 cm apart). eSPPB scores are continuous and range from 0 to 4, with higher scores indicative of better performance.

    baseline and 6, 18, and 30 months

Secondary Outcomes (2)

  • Change in Cardiovascular fitness

    baseline and 18 and 30 months

  • Change in Digit Symbol Substitution Test (DSST)

    baseline and 18 and 30 months

Other Outcomes (3)

  • Change in Gait Speed

    baseline and 18 and 30 months

  • Change in lower extremity muscle strength

    baseline and 18 and 30 months

  • Change in postural sway

    baseline and 18 and 30 months

Study Arms (1)

Community-Dwelling Older Adults

The group will consist of 240 community-dwelling older adults with a range of mobility function based on the short physical performance battery (SPPB).

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

Community-dwelling adults reflecting the gender/race composition of Forsyth County in the target age-range will be identified. The 70 and up age-span was chosen because epidemiologic data shows accelerating functional decline and increased prevalence of white matter abnormalities across this age-range.

You may qualify if:

  • Community-dwelling adults aged ≥70 years
  • Willing to provide informed consent; ability to communicate with study personnel.

You may not qualify if:

  • Serious or uncontrolled chronic disease such as:
  • Cancer (stage 3 or 4) or having had radiation or chemotherapy in the past year
  • Uncontrolled angina
  • Heart failure (stage 3-4)
  • Respiratory disease requiring the use of oxygen
  • Uncontrolled endocrine/metabolic disease (fasting glucose \>250mg/dL)
  • Liver failure (AST \> 40IU/L and/or ALT \> 44 IU/L)
  • Renal failure requiring dialysis
  • Clinically diagnosed neurologic diseases: Parkinson's disease; Amyotrophic Lateral Sclerosis (ALS); Multiple Sclerosis, prior stroke with residual effects lasting longer than 24hrs
  • Diagnosis of schizophrenia, bipolar, or other psychotic disorder
  • Diagnosis of Alzheimer's disease or evidence of impaired cognitive function
  • Prior traumatic brain injury with residual deficits
  • Unwilling or unable to have an MRI brain scan (see MRI screening form).
  • Dependent on a walker or another person to ambulate.
  • Plans to relocate in the next 2- 3 years.
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wake Forest Baptist Medical Center

Winston-Salem, North Carolina, 27157, United States

Location

Related Links

Biospecimen

Retention: SAMPLES WITH DNA

Serum, plasma, and DNA will be retained for later analysis and for future research

MeSH Terms

Conditions

Leukoencephalopathies

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Stephen Kritchevsky, PhD

    Wake Forest University Health Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 26, 2018

First Posted

February 12, 2018

Study Start

July 20, 2018

Primary Completion

July 12, 2023

Study Completion

July 12, 2023

Last Updated

August 18, 2023

Record last verified: 2023-08

Locations